Utama › Glioma Pontin Intrinsik Difus › Florida
Kajian klinikal Glioma Pontin Intrinsik Difus di Florida
7 kajian untuk Glioma Pontin Intrinsik Difus sedang mencari peserta di lokasi di Florida.
Bandar di Florida
Teks kajian rasmi (Bahasa Inggeris)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Nicklaus Children's Hospital, Miami
Mengambil pesertaFasa 2
12 Months – 39 Years · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Johns Hopkins All Children's Hospital, St. Petersburg
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04870944Targeted Pediatric High-Grade Glioma Therapy
- University of Miami, Miami
Mengambil pesertaKajian pemerhatian
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
- Arnold Palmer Hospital for Children, Orlando
- dan 1 lagi
Mengambil pesertaFasa 1/2
Sehingga umur 26 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06465199Study of Olutasidenib and Temozolomide in HGG
- University of Miami Hospital and Clinics, Miami
Mengambil pesertaFasa 2
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Nicklaus Children's Hospital, Miami
Mengambil pesertaFasa 2
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
- Jackson Memorial Hospital, Miami
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 1 hingga 21 · Semua jantina · Dikemas kini 8 Dis 2025 · NCT05956821Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.